Infection, Bacterial Clinical Trial
Official title:
Topical Silver Nanoparticles for Microbial Activity
Silver nanoparticles are one of most nanoparticles use nowadays in the research area because it has specific physical and chemical properties, in medical fields silver nanoparticles can involve in diagnostic and treatment processes. Silver nanoparticles have antibacterial, antiviral, antifungal, antiangiogenic, antioxidant, cosmetics, antitumor, anti-inflammatory, the drug carrier, imaging, water treatment, and biosensing effects. Silver nanoparticles prepared with reducing agent tri-sodium citrate then incorporated in a topical cream to obtain a significant inhibition of the bacterial strains, inhibition of growth of bacterial strains in the face or other parts in the bodies.
1. Preparation of vanishing cream Vanishing cream is an emulsion base which is oil in
water, the oil phase gives the cream shine and pearl look because of stearic acid in the
oil. To form an emulsion, the alkali will react with stearic acid to form stearate soap.
Then mix sodium hydroxide (NaOH) with potassium hydroxide (KOH) to give cream hard and
soft properties.
2. Preparation of cream containing silver nanoparticles Silver nanoparticles will be
produced by using the reduction reaction method. The reaction involves heating silver
nitrate at a high temperature with adding a reducing agent, the particles will produce
as silver nanoparticles in liquid form.
3. Characterization of the Vanishing cream containing drug:
3.1. Drug content: The amount of drug in cream will be determined by taking 100 mg of
the cream formulation and dissolve it in 10 mL of methanol after that it will be
filtrated. In addition, it will be analyzed the content of drug spectrophotometrically
using (UV-VIS) at specific λmax.
3.2. Irritation to skin: In this test, the cream formulation will be applied to four
healthy volunteers which they should not have any sensitivity to the drug. They will
inform about the nature of the formulation and obtain a written approval from them about
the irritation effect of the formulated cream.
4. Anti-microbial studies:
The antifungal action for formula will be studied using different 6 groups volunteers The
inhibition microbial activity for all formulae were compared with known standard
antimicrobial drugs.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05846399 -
CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)
|
Phase 4 | |
Recruiting |
NCT05904535 -
Novel Diagnostic Methods to Identify External Ventricular Drain Associated Infections
|
||
Not yet recruiting |
NCT04075344 -
Effect of a Infection Control Program on the Reduction of Bacterial Contamination on NG Tube Feeding in RCHEs
|
N/A | |
Completed |
NCT05333133 -
High Calorie Formula Intervention on Weight, Length Increment, Total Lymphocyte Counts, TNF-alpha and IGF-1 in Failure to Thrive Children
|
N/A | |
Recruiting |
NCT05950984 -
Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)
|
||
Recruiting |
NCT06283433 -
A Dried Blood Spot Sampling Method for Vancomycin and Creatinine Monitoring for OPAT
|
N/A | |
Recruiting |
NCT06178822 -
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
|
||
Completed |
NCT03688321 -
Probiotic on Prevention of GBS Vaginal Infection During Pregnancy
|
N/A | |
Completed |
NCT03244917 -
Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias
|
N/A | |
Recruiting |
NCT04450680 -
Beta-lactam Therapeutic Drug Monitoring in Singapore
|
||
Completed |
NCT05686577 -
How to Reduce Unnecessary Blood Cultures: Construction and Validation of a Predictive Score for Blood Culture Positivity in Intensive Care
|
||
Recruiting |
NCT06093269 -
Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)
|
Phase 4 | |
Recruiting |
NCT05587283 -
Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women
|
Phase 1 | |
Completed |
NCT04440631 -
Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection
|
||
Active, not recruiting |
NCT05150015 -
ElastoMeric Infusion Pumps for Hospital AntibioTICs
|
N/A | |
Completed |
NCT03816956 -
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
|
Phase 3 | |
Terminated |
NCT03555981 -
Early Kangaroo Mother Care in Gambian Hospitalised Unstable Neonates
|
N/A | |
Completed |
NCT03133312 -
Chlorhexidine Gluconate Versus Povidone-Iodine as Vaginal Preparation Antiseptics Prior to Cesarean Delivery
|
Phase 4 | |
Recruiting |
NCT04800575 -
Comparison of Sterile Gauze and Semi-permeable Film Dressing for Hemodialysis Central Venous Catheter
|
N/A | |
Completed |
NCT03925402 -
Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia
|